HealthLynked Corp. Files 8-K on Officer Changes and Financials

TL;DR

HealthLynked leadership shuffle and financials updated. Check the details.

AI Summary

HealthLynked Corp. filed an 8-K on December 12, 2025, reporting on the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. The filing also includes Regulation FD disclosures and financial statements and exhibits. The report date is December 1, 2025.

Why It Matters

This filing provides crucial updates on the company's leadership and financial reporting, which can impact investor confidence and strategic direction.

Risk Assessment

Risk Level: medium — Changes in directors or officers, especially if numerous or related to compensation, can indicate internal shifts that may affect future performance.

Key Players & Entities

• HealthLynked Corp. (company) — Registrant
• December 1, 2025 (date) — Earliest event reported
• December 12, 2025 (date) — Filing date
• Nevada (jurisdiction) — State of incorporation
• 47-1634127 (tax_id) — IRS Employer Identification No.
• 1265 Creekside Parkway, Suite 302, Naples FL 34108 (address) — Principal executive offices
• 800-928-7144 (phone_number) — Registrant's telephone number

FAQ

Key Financial Figures

• $40M — ighted by his leadership for a targeted $40M ground up new construction project in M
• $200 million — sfully facilitating the closing of over $200 million of funded projects. Mr. McGillivray als
• $120,000 — t Mr. McGillivray's base salary will be $120,000 per year initially and increase to $150
• $150,000 — ,000 per year initially and increase to $150,000 if the Company successfully uplists to
• $20,000 — ll receive annual compensation equal to $20,000 in shares of Company common stock that
• $1 — Capital, a family office that maintains $1–2 million in strategic micro-cap positi
• $70 million — al Foundation, helping manage more than $70 million in assets and acting as Chairman during

Filing Documents

• ea0269326-8k_health.htm (8-K) — 34KB
• ea026932601ex99-1_health.htm (EX-99.1) — 17KB
• ea026932601ex99-2_health.htm (EX-99.2) — 14KB
• 0001213900-25-121170.txt ( ) — 235KB
• hlyk-20251201.xsd (EX-101.SCH) — 3KB
• hlyk-20251201_lab.xml (EX-101.LAB) — 33KB
• hlyk-20251201_pre.xml (EX-101.PRE) — 22KB
• ea0269326-8k_health_htm.xml (XML) — 3KB

02 Departure of

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment of Chief Operating Officer On December 8, 2025, HealthLynked Corp., a Nevada corporation (the " Company "), appointed Duncan McGillivray, age 65, as its Chief Operating Officer, effective immediately. Mr. McGillivray brings more than 30 years of executive leadership across healthcare, technology, capital markets, and large-scale project finance. From September 2022 to August 30, 2024, Mr. McGillivray served as the President of HWH Community Development Group, LLC, a U.S. Treasury nationally licensed community development entity for financing capital projects, where Mr. McGillivray provided capital project funding guidance to a wide range of construction projects highlighted by his leadership for a targeted $40M ground up new construction project in Miami. Prior to this, Mr. McGillivray served as a senior capital project consultant for Capital Link, a national cooperative partner of the U.S. Department of Health (HRSA). Mr. McGillivray provided strategic planning, business plans and corporate financial consulting for community health facilities across the USA which included successfully facilitating the closing of over $200 million of funded projects. Mr. McGillivray also served as the U.S. HRSA's national webinar leader to provide capital project financing guidance to the nation's 1,400 Federally Qualified Health Centers. Mr. McGillivray has 35 years of professional experience including work for Union Bank, Morgan Guaranty Trust, Bank of America, Bank of California and operating a family-owned business valuation company named Veritas Valuation Specialists, Inc. The Company and Mr. McGillivray have agreed that Mr. McGillivray's base salary will be $120,000 per year initially and increase to $150,000 if the Company successfully uplists to the Nasdaq Capital Market (an "Uplisting"). Mr. McGillivra

01 Regulation

Item 7.01 Regulation FD Disclosure. Furnished as Exhibit 99.1 and Exhibit 99.2 of this Current Report on Form 8-K are press releases issued by the Company with regard to Mr. McGillivray's appointment as Chief Operating Officer and Mr. Pulos's and Mr. Bishara's appointments as directors, respectively. These press releases shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information in this Item 7.01 and Exhibit 99.1 and Exhibit 99.2 of this Current Report on Form 8-K shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Current Report, regardless of any general incorporation language in any such filing.

01. Financial

Item 9.01. Financial (d) Exhibits Exhibit No. Exhibit Title or Description 99.1 Press Release dated December 2, 2025 99.2 Press Release dated December 8, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized. HEALTHLYNKED CORP. Date: December 12, 2025 /s/ Jeremy Daniel Jeremy Daniel Chief Financial Officer 3

View Full Filing

View this 8-K filing on SEC EDGAR